Clearline Capital’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-577,800
| Closed | -$4.28M | – | 173 |
|
|
2021
Q3 | $4.28M | Buy |
+577,800
| New | +$4.28M | 0.4% | 53 |
|
|
2019
Q3 | – | Sell |
-37,258
| Closed | -$608K | – | 64 |
|
|
2019
Q2 | $608K | Buy |
+37,258
| New | +$608K | 0.3% | 41 |
|
|
2015
Q4 | – | Sell |
-516,804
| Closed | -$5.68M | – | 61 |
|
|
2015
Q3 | $5.68M | Buy |
516,804
+28,812
| +6% | +$317K | 0.96% | 26 |
|
|
2015
Q2 | $6.35M | Buy |
487,992
+244,286
| +100% | +$3.18M | 0.88% | 29 |
|
|
2015
Q1 | $4.23M | Sell |
243,706
-6,844
| -3% | -$119K | 0.63% | 41 |
|
|
2014
Q4 | $3.74M | Buy |
+250,550
| New | +$3.74M | 0.58% | 43 |
|